AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 2 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- 8 awardsAwards on record
Key stats
Fundamentals Sep 26- Open
- $97.54
- 52-wk high
- $100.93
- High
- $98.45
- 52-wk low
- $66.41
- Low
- $96.67
- Prev close
- $97.25
- Mkt cap
- $62.09B
- P/E
- 18.7x
- Volume
- 3.63M
- Fwd P/E
- 10.5x
- Beta
- 0.76
- Div yield
- 2.36%
- P/S
- 0.8x
- P/B
- 2.2x
- Profit margin
- +4.6%
- Op margin
- +5.5%
- ROE
- +13.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MET filings
Are insiders buying or selling MetLife Inc (MET) stock?
Neither. MetLife Inc (MET) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded MET recently?
None. No member of Congress disclosed a MET trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MET smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- GA
Gotham Asset
$10.5M
added
Sells/Trims (2)
- QR
Qube Research
$91.2M
trimmed
- MI
Millennium
$62.6M
trimmed
What insiders are doing
Sells (1)
- DM
Debel Marlene
$1.7M
sold
How top traders are positioned
Earnings
Earnings came in 5.7% above what analysts expected.
Earnings per share
$2.30 expected
Reports Sep 30, 2026, in 3 days
Estimates as of Sep 26, 2026
EPS expected
$2.39 to $2.71
Revenue expected
5 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $16.88B | $23.81B | $19.07B | $18.88B |
| Cost of what it sold | $13.94B | $16.54B | $11.97B | $16.09B |
| Gross profit | $2.94B | $7.27B | $7.10B | $2.79B |
| What it spent | ||||
| Sales and admin | $1.53B | $3.73B | $1.70B | $1.69B |
| Other operating costs | $198.0M | $2.42B | $3.90B | $65.0M |
| Total operating expenses | $1.73B | $6.15B | $5.60B | $1.75B |
| What was left | ||||
| Operating profit | $1.21B | $1.12B | $1.51B | $1.03B |
| Interest on debt | $271.0M | $263.0M | $265.0M | $292.0M |
| Profit before tax | $1.21B | $1.12B | $1.51B | $1.03B |
| Tax | $308.0M | $301.0M | $345.0M | $256.0M |
| Net profit | $896.0M | $809.0M | $1.19B | $736.0M |
| EBITDA | $1.48B | $1.38B | $1.77B | $1.33B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
MET.GL Bond Profile: Coupon and Redemption
NeutralSep 26MetLife stock trades at USD 97.25 as Q3 estimate emerges
Leans bullishSep 25MetLife stock heads into the open after Q3 investment update
Leans bullishSep 25MetLife Q3FY26 Results: Variable investment income guided to $600M
Leans bullishSep 25MetLife sees Q3 variable investment income at least $600 million pretax
BullishSep 25MET3887852 Bond Profile: Coupon and Redemption
NeutralSep 25MET4969015 Bond Profile: Coupon and Redemption
NeutralSep 24UBS AG Prices MetLife-Linked Contingent Income Securities at 100% Issue Price
NeutralSep 24